COPD/ILD Stem Cell Therapy - Chronic Obstructive Pulmonary Disease Treatment
MSC therapy for COPD and interstitial lung disease. Reduces airway inflammation, improves lung function, decreases exacerbation frequency, enhances breathing capacity.
Stem cell therapy addressing chronic airway inflammation and lung tissue damage in COPD/ILD patients.
- Chronic Obstructive Pulmonary Disease (COPD)
- Interstitial Lung Disease (ILD)
- Emphysema
- Chronic Bronchitis
- Reduces airway inflammation
- Improves FEV1 and FVC metrics
- Decreases acute exacerbation frequency
- Enhances oxygen saturation
- Improves exercise tolerance and quality of life
COPD/ILD干细胞治疗 - 慢性阻塞性肺病治疗
用于COPD和间质性肺病的MSC治疗。减轻气道炎症、改善肺功能、减少急性加重频率、增强呼吸能力。
针对COPD/ILD患者慢性气道炎症和肺组织损伤的干细胞治疗。
- 慢性阻塞性肺病(COPD)
- 间质性肺病(ILD)
- 肺气肿
- 慢性支气管炎
- 减轻气道炎症
- 改善FEV1和FVC指标
- 减少急性加重频率
- 提高血氧饱和度
- 改善运动耐量和生活质量